Physician profile
Amanda Parker Mitchell
NPI 1144875501
$1,623.54
in general payments reported to CMS, 2019-2025
17 companies · $496 in 2025
The $496 reported for 2025 was more than what 92% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $145 · 2022: $284 · 2023: $358 · 2024: $341 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,195.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $578.11 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $197.24 | 2022-2024 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $144.97 | 2025 | |
| Neos Therapeutics, LP | $123.22 | 2021-2024 | Cotempla Xr-Odt |
| Cranial Technologies, INC | $98.31 | 2022-2025 | Doc Band |
| Collegium Pharmaceutical, INC. | $80.58 | 2025 | Jornay Pm |
| Tris Pharma INC | $68.78 | 2021-2022 | |
| Seqirus USA INC | $52.05 | 2021-2023 | Flucelvax Quadrivalent |
| Pfizer INC. | $48.08 | 2023-2025 | |
| Aytu Biopharma, INC. | $41.73 | 2021-2022 | |
| Sanofi Pasteur INC. | $41.33 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $32.42 | 2021-2024 | Flumist Quadrivalent |
| Merck Sharp & Dohme LLC | $29.82 | 2025 | Enflonsia, Vaxneuvance, Vaxelis |
| Glaxosmithkline, LLC. | $24.61 | 2023 | |
| Sobi, INC | $21.90 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $20.37 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.